nifedipine has been researched along with Movement Disorders in 3 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
Excerpt | Relevance | Reference |
---|---|---|
"Haloperidol (Hal) is an antipsychotic related to movement disorders." | 3.91 | Influence of magnesium supplementation and L-type calcium channel blocker on haloperidol-induced movement disturbances. ( Burger, ME; da Silva Barcelos, RC; Kronbauer, M; Metz, VG; Milanesi, LH; Roversi, K; Rubert Rossato, D, 2019) |
"Haloperidol is a classical neuroleptic drug that is still in use and can lead to abnormal motor activity such as tardive dyskinesia (TD) following repeated administration." | 1.35 | Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kronbauer, M | 1 |
Metz, VG | 1 |
Roversi, K | 1 |
Milanesi, LH | 1 |
Rubert Rossato, D | 1 |
da Silva Barcelos, RC | 1 |
Burger, ME | 1 |
Bishnoi, M | 1 |
Chopra, K | 1 |
Kulkarni, SK | 1 |
Guelrud, M | 1 |
Mendoza, S | 1 |
Rossiter, G | 1 |
Ramirez, L | 1 |
Barkin, J | 1 |
1 trial available for nifedipine and Movement Disorders
Article | Year |
---|---|
Effect of nifedipine on sphincter of Oddi motor activity: studies in healthy volunteers and patients with biliary dyskinesia.
Topics: Adult; Ampulla of Vater; Blood Pressure; Common Bile Duct Diseases; Female; Heart Rate; Humans; Male | 1988 |
2 other studies available for nifedipine and Movement Disorders
Article | Year |
---|---|
Influence of magnesium supplementation and L-type calcium channel blocker on haloperidol-induced movement disturbances.
Topics: Animals; Antipsychotic Agents; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Corpus Str | 2019 |
Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study.
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Calcium Channel Blockers; Calcium Cha | 2008 |